The Athena Award 2022
| Reference number | |
| Coordinator | Bonnier Business Media Sweden AB |
| Funding from Vinnova | SEK 117 500 |
| Project duration | October 2022 - December 2022 |
| Status | Completed |
Important results from the project
** Denna text är maskinöversatt ** The 2022 Athena Prize was awarded on October 25 to Stratipath, an AI-based decision support for prognostic analysis of breast cancer directly from microscopy images. The purpose of the Athena Prize is to reward and draw attention to research that has taken place in collaboration between healthcare, academia and industry. Stratipath meets the criteria for the award well and is an exciting example of how artificial intelligence can be used in medicine to provide equal access to diagnosis and treatment.
Expected long term effects
** Denna text är maskinöversatt ** The purpose of the Athena prize is to draw attention to clinical research and innovation that takes place in collaboration between healthcare, academia and industry and produces a positive results in the form of: Benefit for healthcare and patients. High scientific quality A new method, product or technology that has been developed or improved. The researchers behind Stratipath has developed a tool that brings significant benefits to both healthcare and patients by enabling cost-effective and equivalent precision medicine diagnostics.
Approach and implementation
** Denna text är maskinöversatt ** The call for proposals for the Athena prize was made in April 2022 and took place through articles in the newspaper Dagens Medicin,nformation mailings to target groups in healthcare, research institutions, regions, authorities and incubators. We received approximately 25 nominations in the first round of applications, of which six were selected by the jury to proceed to the next stage of the judging process. Of these six, a winner was selected at the jury meeting in September.